Emerging economic and technological trends in the clinical diagnostic market. Diagnostics market and reports on regulatory, reimbursement, and policy issues that impact the commercial operations of clinical labs.

360Dx is published by GenomeWeb, an independent online news organization based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and diagnostics. GenomeWeb is a family brand of Crain Communications. 360Dx, launched in 2016, covers emerging ...

Jan 27, 2025 · The test, which is intended for assessing cardiovascular risk, is the first lipoprotein (a), or Lp (a), test measured in nanomoles per liter to receive FDA clearance.

1 day ago · NEW YORK – Siemens Healthineers on Thursday said it posted a 1 percent rise in diagnostics adjusted revenues year over year for its fiscal first quarter while its overall revenues grew by 6 percent.

News and analysis on diagnostic technologies and applications from 360Dx.

4 days ago · Editor’s Note: We have adjusted the firms listed in the 360Dx Top 30 this month based on market caps at the end of 2024. Grail, Personalis, and Tempus AI have been added in place of MDxHealth, Biodesix, and Sera Prognostics. Companies represented in the Top 30 must trade common stock on one of the major US stock exchanges. NEW YORK – The 360Dx Top 30 jumped nearly 10 percent month over ...

360Dx is the leading source for breaking news and in-depth analysis on the clinical lab and in vitro diagnostics markets. A free 360Dx account gives you instant access to real-time reporting on the lab industry while a Premium account provides the very best of our science, business, and technology journalism. Explore your subscription options below.

Jan 2, 2025 · Editor’s Note: We will adjust the firms listed in the 360Dx Top 30 this month based on market caps at the end of 2024. Those changes will be reflected next month when we report on the stock performance in January of the companies we track. NEW YORK – After two years of decline in 2022 and 2023, the 360Dx Top 30 rebounded in 2024, rising 4 percent year over year. The increase correlated ...

Stay current with Diagnostics business news. Financial news, mergers and acquisitions, partnerships, and alliances from 360Dx.

Jul 29, 2024 · The program, which involves government contracts for certain types of in vitro diagnostic testing, could determine which companies thrive in China.